A.G. Schneiderman Announces Settlement with Pfizer to End Deceptive Advertising Practices and Off-label Promotion of Immunosuppressive Drug Rapamune
NEW YORK -- Attorney General Eric T. Schneiderman today announced that he, along with 40 other state Attorneys General and the District of Columbia, reached a $35 million settlement with Pfizer arising from alleged improper marketing and promotion of the immunosuppressive drug Rapamune. New York's share of the settlement is over $1.7 million. Pfizer, as parent of Wyeth Pharmaceuticals Inc., agrees to be bound by the judgment and to resolve allegations that Wyeth unlawfully promoted Rapamune. Attorney General Schneiderman's office served on the Executive Committee of this multi-state investigation.
- Date:August 6, 2014
- Agency:New York Attorney General
- State Enforcement Agencies